Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
Aim: The aim of this study was to evaluate the benefits and safety of long-term i.v. iron therapy
Aim: The aim of this study was to evaluate the benefits and safety of long-term i.v. iron therapy
Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Management of HF involves accurate
Iron deficiency and iron-deficiency anemia are global health problems and common medical conditions seen in everyday clinical
Aim: To obtain preliminary safety and efficacy data on intravenous (IV) administration of infliximab (IFX) and ferric
Anaemia is the most common systemic complication and extraintestinal manifestation of inflammatory bowel disease [IBD].
Aim: Anaemia and iron deficiency are constituents of the cardio-renal syndrome in chronic heart failure (CHF). We investigated
Iron deficiency is a common nutritional deficiency amongst women of childbearing age. Peri-partum iron deficiency anaemia (IDA)
Systematic review and meta-analysis of randomised controlled trials comparing IV iron with no iron or oral iron for
Aim:
The purpose of this study was to evaluate the cost-effectiveness of iron repletion using intravenous (i.v.)
Chronic diseases reduce the availability of iron for effective erythropoiesis. This review summarises clinical consequences of iron